Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
20.59
+0.10 (0.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
KNSA Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KNSA stock have an average target of 36.6, with a low estimate of 34 and a high estimate of 40. The average target predicts an increase of 77.76% from the current stock price of 20.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for KNSA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +94.27% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +69.99% | Oct 30, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +94.27% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +65.13% | Jul 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +65.13% | May 3, 2024 |
Financial Forecast
Revenue This Year
432.54M
from 270.26M
Increased by 60.05%
Revenue Next Year
589.66M
from 432.54M
Increased by 36.32%
EPS This Year
-0.47
from 0.20
EPS Next Year
0.56
from -0.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 451.5M | 643.8M | 742.4M | |||
| Avg | 432.5M | 589.7M | 697.3M | |||
| Low | 413.5M | 544.9M | 633.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.1% | 48.8% | 25.9% | |||
| Avg | 60.0% | 36.3% | 18.2% | |||
| Low | 53.0% | 26.0% | 7.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.08 | 1.05 | 1.13 | |||
| Avg | -0.47 | 0.56 | 0.73 | |||
| Low | -0.60 | 0.21 | 0.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 101.2% | |||
| Avg | - | - | 30.3% | |||
| Low | - | - | -28.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.